Life Science ecosystem in Milan: meeting with Swiss delegation
The Centre for Innovation and Technology Transfer (CITT) at Human Technopole and the Swiss diplomatic representation in Italy, in collaboration with YES MILANO, organised a day-long meeting between Swiss and Italian players working in the field of life sciences. The initiative followed a study tour that CITT experienced in Switzerland in June 2022 to get to know partners in the Swiss innovation ecosystem and pave the way for future collaborations and sharing of best practices on the topic of technology transfer.
The meeting, hosted at the Human Technopole headquarters within MIND – Milano Innovation District, allowed the various entities involved to initiate new relationships and strengthen existing ones.
The programme for the day included a presentation of the Milan life sciences ecosystem, coordinated by Piergiorgio Borgogelli of YES MILANO and involving: Margherita Chierici (TTO IRCCS Ca’ Granda Ospedale Maggiore Policlinico), Daniela Bellomo (Business Development Director San Raffaele), Stefano Minini (Director Lendlease), Felice Lopane (Life Sciences Assolombarda Coordinator), Francesco Cerruti (General Manager Italian Tech Alliance), Paola Testori Coggi (Ambassador Federated Innovation MIND). In the second part of the programme, the Swiss delegation had the opportunity to introduce themselves to the Italian delegates in a pitching session followed by bilateral meetings.
Attached is a copy of the program.
Share:
You could also like:
-
Two ERC-funded projects to search for tumours’ weaknesses
Human Technopole has once again been awarded by Europe’s prestigious public body for funding of scientific research conducted within the European Union, the European Research Council (ERC), for two projects on the origin of tumours, their evolution and the development of resistance to therapies. The two studies could contribute to the identification of new anti-cancer targeted […]
-
COVID-19: How SARS‑CoV‑2 Enters Human Cells
A study by the University of Padua and Human Technopole, together with the University of Milan and the European Institute of Oncology, published in Cell Reports Medicine, reveals that SARS-CoV-2, the virus that causes COVID-19, binds the RAGE receptor present on the surface of specific human immune cells to penetrate them and pathologically alter their function. This study also shows how the involvement of RAGE, previously known only in the context of other pathophysiological conditions, such as obesity and diabetes, is implicated in the degree of severity with which COVID-19 can manifest.
-
Italy joins the iCARE4CVD consortium
The Human Technopole and Mario Negri institute for Pharmacological Research are among 33 leading international partners who have joined forces to better understand cardiovascular diseases and optimise future prevention and treatment.
-
Study tour “Austrian Life Science Innovation Ecosystem” in Vienna
The Human Technopole Centre for Innovation and Technology Transfer (CITT) continues its international promotion activities by learning about foreign innovation ecosystems. From 28 to 30 November 2023, CITT is organising a study tour to meet the leading players in basic and applied research within the Austrian ecosystem, with the support of the Italian Embassy in Vienna and the Italian Trade Agency.
-
Annotating human genes: where do we stand now?
In a perspective article published in Nature, Piero Carninci and colleagues discuss the status of human gene annotation and how high-throughput RNA sequencing technologies have accelerated the discovery of non-coding RNA genes with unknown functions and will promote the completion of the human gene catalogue.